Skip to main content
Springer logoLink to Springer
. 2021 Jan 7;303(2):513–514. doi: 10.1007/s00404-020-05925-4

Correction to: Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16/Ki-67: a randomized controlled trial

Attila Louis Major 1,2,, Vladimír Dvořák 3, Jana Schwarzová 4, Aleš Skřivánek 5, Tomáš Malík 6, Marek Pluta 7, Ivanna Mayboroda 8, Etienne Marc Grandjean 9,10
PMCID: PMC8025267  PMID: 33415439

Correction to: Archives of Gynecology and Obstetrics 10.1007/s00404-020-05816-8

In the original article published, there was an error in figure 2. “Fehlt Rahmen links” was a comment in German as an information that the frame was missing in figure 2. The typesetter misunderstood this correction. The correct word is “Cytology at Baseline” and this 2 times (for the active as well as for the control group) in Fig. 2.

Fig. 2.

Fig. 2

Difference in cytological findings after 6 months in the active and control arm. Shadings illustrate different cytological changes. Dark grey, remission to non-conspicuous finding or regression to a lower grade. Grey, persistence. Light grey, progression to a higher grade. NILM, negative for intraepithelial lesion or malignancy; ASC-US, atypical squamous cells of undetermined significance; AGC, atypical glandular cells; ASC–H, atypical squamous cells cannot exclude HSIL; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion. *Fisher’s two-tailed exact test and Pearson’s chi-squared test; p < 0.001

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Archives of Gynecology and Obstetrics are provided here courtesy of Springer

RESOURCES